TABLE 2.
Proportion N384/N384-3 | Simulated (NanoSim) (×) |
Amplicon DNA (×) |
Culture (×) |
|||
---|---|---|---|---|---|---|
BWA/BCFtools | Medaka | BWA/BCFtools | Medaka | BWA/BCFtools | Medaka | |
100% N384 | 0 | 0 | 200 (exclude C > T) | NA | 0 (C > T at 10) | NA |
90% N384 | 5 | 5 | 10 | NA | 150 | NA |
10% N384-3 | ||||||
80% N384 | 5 | NA | ||||
20% N384-3 | ||||||
70% N384 | 10 | NA | ||||
30% N384-3 | ||||||
60% N384 | 5 | 5 | ||||
40% N384-3 | ||||||
50% N384 | 2 | 5 | 20 | 80 | 5 | 20 |
50% N384-3 | ||||||
40% N384 | 2 | 2 | ||||
60% N384-3 | ||||||
30% N384 | 2 | 2 | ||||
70% N384-3 | ||||||
20% N384 | 3 | 20 | ||||
80% N384-3 | ||||||
10% N384 | 2 | 2 | 2 | 2 | 3 | 3 |
90% N384-3 | ||||||
100% N384-3 | 10 | 10 | 2 | 2 | 2 | 2 |
Cases in which the mutation was never detected are listed as NA.